Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease

被引:25
作者
ZuWallack, RL
Haggerty, MC
Jones, P
机构
[1] St Francis Hosp & Med Ctr, Sect Pulm & Crit Care, Hartford, CT 06105 USA
[2] Norwalk Hosp, Sect Pulm & Crit Care Med, Div Pulm Rehabil, Norwalk, CT 06856 USA
[3] Univ London St Georges Hosp, London, England
关键词
D O I
10.1016/j.amjmed.2004.10.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic obstructive pulmonary disease, (COPD) is characterized by chronic airflow limitation, gas exchange abnormalities, hyperinflation, and other pathophysiologic events. However, patients are usually unaware of these physical changes an only seek medical attention when distressing symptoms, such as dyspnea and exercise limitation, be in to appear. Therefore, it is reasonable to directly assess these clinical areas, of importance to the patient, both as determinants of,the impact of the disease process and as outcomes following, intervention. Although many of the physiologic abnormalities of COPD are only partially or poorly reversible with treatment, dyspnea, exercise performance, and health status often show impressive gains with therapy. Incorporating clinically relevant outcome assessments, complements traditional physiologic measurements and provides the clinician with a yardstick to determine whether a particular intervention is causing a meaningful improvement in the patient. This article discusses these clinical assessments and provides specific examples of their applicability and usefulness in treating patients with COPD.
引用
收藏
页码:49S / 59S
页数:11
相关论文
共 61 条
[1]   Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation [J].
Aaron, SD ;
Vandemheen, KL ;
Clinch, JJ ;
Ahuja, J ;
Brison, RJ ;
Dickinson, G ;
Hébert, PC .
CHEST, 2002, 121 (03) :688-696
[2]  
*AM THOR SOC, 1995, AM J RESP CRIT CARE, pS77
[3]  
American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666
[4]  
[Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1
[5]   Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease [J].
Belman, MJ ;
Botnick, WC ;
Shin, JW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) :967-975
[6]   PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION [J].
BORG, GAV .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) :377-381
[7]   Exercise training in chronic obstructive pulmonary disease [J].
Bourjeily, G ;
Rochester, CL .
CLINICS IN CHEST MEDICINE, 2000, 21 (04) :763-+
[8]   Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD [J].
Brusasco, V ;
Hodder, R ;
Miravitlles, M ;
Korducki, L ;
Towse, L ;
Kesten, S .
THORAX, 2003, 58 (05) :399-404
[9]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[10]   2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].
BUTLAND, RJA ;
PANG, J ;
GROSS, ER ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608